Displaying results 1 - 12 of 15
COVID-19 and the liver
EASL Policy Statement on the Use of COVID-19 Vaccines in People with Chronic Liver Disease, Hepatobiliary Cancer, and Liver Transplant Recipients

EASL Policy Statement on the Use of COVID-19 Vaccines in People with Chronic Liver Disease, Hepatobiliary Cancer, and Liver Tr...

PDF
View
Liver Tumours
EASL Studio S1 E1: Liver Cancer Awareness Month

EASL Studio S1 E1: Liver Cancer Awareness Month

EASL Studio
View
Metabolism, Alcohol & Toxicity

Introduction and presentation of the NAFLD patient guideline

Webcasts
View
Metabolism, Alcohol & Toxicity

The user perspective

Webcasts
View
Metabolism, Alcohol & Toxicity

Changing the models of care

Webcasts
View
Metabolism, Alcohol & Toxicity

A practical example from the guideline

Webcasts
View
Metabolism, Alcohol & Toxicity

A multidisciplinary patient-centred approach

Webcasts
View
Metabolism, Alcohol & Toxicity
Non-alcoholic fatty liver disease: A patient guideline

Non-alcoholic fatty liver disease: A patient guideline

PDF
View
Liver Tumours
Liver Cancer Explained

Liver Cancer Explained

Infographics
View
General Hepatology
Public health

Public health

Best of International Liver Congress (ILC)
View
General Hepatology
ILC 2021 Takeaways – Public health

ILC 2021 Takeaways – Public health

Takeaways
View
COVID-19 and the liver
Ask EASL: podcast on COVID-19 vaccination in patients with liver disease

Ask EASL: podcast on COVID-19 vaccination in patients with liver disease

Podcasts
View
Displaying results 1 - 12 of 15